Literature DB >> 12665394

Streptokinase for the treatment of acute ischaemic stroke : towards better strategies.

Blas Y Betancourt, Jaime Parellada-Blanco, Pedro López-Saura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12665394     DOI： 10.2165/00023210-200317050-00006

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  6 in total

Review 1.  Optimal timing of thrombolytic therapy in acute ischaemic stroke.

Authors:  Ken Madden
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Thrombolytic therapy with streptokinase in acute ischemic stroke.

Authors:  Marc Hommel; C Cornu; F Boutitie; J P Boissel
Journal:  N Engl J Med       Date:  1996-07-18       Impact factor: 91.245

3.  TERIMA-2: national extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba.

Authors: 
Journal:  Thromb Haemost       Date:  2000-12       Impact factor: 5.249

4.  Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

Authors:  G A Donnan; S M Davis; B R Chambers; P C Gates; G J Hankey; J J McNeil; D Rosen; E G Stewart-Wynne; R R Tuck
Journal:  JAMA       Date:  1996-09-25       Impact factor: 56.272

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors: 
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.